[90Y] yttrium-capromab pendetide

N/A

Report date: 2025/11/24 17:27:28

Base Information

Drug Name[90Y] yttrium-capromab pendetide

Drug Alias Nameyttrium-90-labeled anti-PSMA monoclonal antibodyPR356OncoRad PR356

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Radioactive therapeutic agent +[5]

Mechanisms of ActionProstate-specific antigen modulators

TargetsProstate-specific antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesJazz Pharmaceuticals Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJazz Pharmaceuticals Plc

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A